Pharmacokinetics of antidepressants: why and how they are relevant to treatment

J Clin Psychiatry. 1993 Sep:54 Suppl:14-34; discussion 55-6.

Abstract

The pharmacokinetics of antidepressants are reviewed with special emphasis on clinical applicability. There are substantial pharmacokinetic differences among the five major classes. Pharmacokinetic differences between members of a specific class are usually modest except for serotonin selective reuptake inhibitors. Between members of this class pharmacokinetic differences are the major distinguishing variables and have clinically important consequences.

Publication types

  • Review

MeSH terms

  • Antidepressive Agents / pharmacokinetics*
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Antidepressive Agents, Tricyclic / pharmacokinetics
  • Antidepressive Agents, Tricyclic / pharmacology
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Biological Availability
  • Bupropion / pharmacokinetics
  • Bupropion / pharmacology
  • Bupropion / therapeutic use
  • Depressive Disorder / drug therapy*
  • Drug Monitoring
  • Half-Life
  • Humans
  • Monoamine Oxidase Inhibitors / pharmacokinetics
  • Monoamine Oxidase Inhibitors / pharmacology
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Trazodone / pharmacokinetics
  • Trazodone / pharmacology
  • Trazodone / therapeutic use

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
  • Monoamine Oxidase Inhibitors
  • Serotonin Uptake Inhibitors
  • Bupropion
  • Trazodone